Literature DB >> 17922931

HIV subtypes in Scotland, 2000-2006.

D L Yirrell1, L Shaw, E Campbell, S M Burns, S O Cameron, D Goldberg.   

Abstract

The purpose of this study was to document the dynamics of HIV-1 subtypes in Scotland over a 6-year period. Viral RNA from all-new diagnoses was amplified by nested PCR and sequenced in the gag and/or env regions. Subtype was assigned by phylogenetic analysis, and aligned with demographic data including likely route and geographical origin of infection. We present data on 80% of all new diagnoses in Scotland between April 2000 and April 2006. Within the background of an expanding epidemic, subtype B predominates in men who have sex with men and intravenous drug users but there is a small but consistent number of UK-acquired infections in these risk groups caused by non-B subtypes. In heterosexuals, non-B subtypes acquired abroad, especially Africa, are still the largest group but again UK-acquired numbers are rising. The social and clinical significance of the spread of non-B subtypes in different ethnic and risk groups remains to be established.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17922931      PMCID: PMC2870891          DOI: 10.1017/S0950268807009545

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  13 in total

Review 1.  Genetic diversity of HIV in Africa: impact on diagnosis, treatment, vaccine development and trials.

Authors:  Martine Peeters; Coumba Toure-Kane; John N Nkengasong
Journal:  AIDS       Date:  2003-12-05       Impact factor: 4.177

2.  Young people: force for change.

Authors: 
Journal:  SAfAIDS News       Date:  1998-12

Review 3.  HIV-1 subtype distribution and the problem of drug resistance.

Authors:  Mark A Wainberg
Journal:  AIDS       Date:  2004-06       Impact factor: 4.177

4.  HIV-1 subtype dynamics over 10 years in a rural Ugandan cohort.

Authors:  David L Yirrell; Pontiano Kaleebu; Dilys Morgan; Sharon Hutchinson; James A Whitworth
Journal:  Int J STD AIDS       Date:  2004-02       Impact factor: 1.359

5.  The relationship between HIV type 1 disease progression and V3 serotype in a rural Ugandan cohort.

Authors:  David Senkaali; Richard Muwonge; Dilys Morgan; David Yirrell; James Whitworth; Pontiano Kaleebu
Journal:  AIDS Res Hum Retroviruses       Date:  2004-09       Impact factor: 2.205

Review 6.  HIV-1 subtypes: epidemiology and significance for HIV management.

Authors:  Anna Maria Geretti
Journal:  Curr Opin Infect Dis       Date:  2006-02       Impact factor: 4.915

7.  Inter- and intra-genic intersubtype HIV-1 recombination in rural and semi-urban Uganda.

Authors:  David L Yirrell; Pontiano Kaleebu; Dilys Morgan; Christine Watera; Brian Magambo; Frederick Lyagoba; James Whitworth
Journal:  AIDS       Date:  2002-01-25       Impact factor: 4.177

8.  Why do HIV-1 subtypes segregate among persons with different risk behaviors in South Africa and Thailand?

Authors:  T D Mastro; C Kunanusont; T J Dondero; C Wasi
Journal:  AIDS       Date:  1997-01       Impact factor: 4.177

9.  A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors.

Authors:  Bluma Brenner; Dan Turner; Maureen Oliveira; Daniela Moisi; Mervi Detorio; Mauricio Carobene; Richard G Marlink; Jonathan Schapiro; Michel Roger; Mark A Wainberg
Journal:  AIDS       Date:  2003-01-03       Impact factor: 4.177

Review 10.  Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance.

Authors:  Shalom Spira; Mark A Wainberg; Hugues Loemba; Dan Turner; Bluma G Brenner
Journal:  J Antimicrob Chemother       Date:  2003-02       Impact factor: 5.790

View more
  1 in total

1.  Molecular surveillance of HIV-1 in Madrid, Spain: a phylogeographic analysis.

Authors:  José M González-Alba; Africa Holguín; Rosa Garcia; Silvia García-Bujalance; Roberto Alonso; Avelina Suárez; Rafael Delgado; Laura Cardeñoso; Rosa González; Isabel García-Bermejo; Francisca Portero; Carmen de Mendoza; Fernando González-Candelas; Juan-Carlos Galán
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.